Ibogaine for depression, PTSD and trauma

Evidence level: C Emerging evidence — observational studies and case series, no randomised controlled trials yet. We say so wherever it matters.

We should start with the limitation rather than the promise, because on this subject the two are frequently reversed.

Ibogaine’s published clinical evidence concerns substance dependence. The peer-reviewed studies from the Brazilian hospital programme that informs much of this site examined alcohol, cannabis, cocaine and crack dependence — not depression, and not PTSD. Research into ibogaine for trauma and mood conditions is genuinely under way and genuinely interesting, but it is early, and nobody can honestly present it as established.

What can be said with more confidence is narrower and, for many people reading this, more relevant: where trauma or depression sits underneath a dependence, ibogaine’s effect on that underlying material is well described clinically — and it is often the part that conventional addiction treatment never reached.

Where the interest comes from

Two observations drive it.

The first is clinical. Patients treated for addiction consistently report improvements that extend well beyond substance use — in mood, anxiety, and the sense of being able to manage their own lives. The 2016 qualitative study of the Brazilian programme documented exactly this: alongside reduced craving, patients described improvements in personal relationships, quality of life and self-efficacy.

The second is the nature of the experience itself. Ibogaine produces a prolonged introspective state in which autobiographical material surfaces with unusual clarity — and, as clinicians consistently observe, the material that surfaces relates directly to the problems the person is actually living with, including things they had not previously been able to look at.

For anyone whose depression or PTSD is rooted in specific experience rather than in nothing at all, that is an obvious point of interest. It is not, by itself, evidence.

The strongest case — trauma beneath dependence

This is where the clinical rationale is most solid, and it describes a large proportion of the people who contact us.

Long-term dependence very often sits on top of something: unresolved trauma, chronic anxiety, emotional exhaustion, depression that predates the drinking or the drugs. Conventional addiction treatment frequently addresses the substance and leaves that foundation untouched — which is a common reason people relapse after completing programmes that appeared to work.

Ibogaine’s role here is specific. It interrupts withdrawal and craving, which removes the noise, and opens a period in which that underlying material becomes accessible. The psychotherapy that follows is what addresses it.

This is why the programme behind the published research treats ibogaine as a facilitator of psychotherapy rather than as a treatment in itself, and why patients unwilling to engage in psychological work are not accepted at all.

If your situation is dependence with trauma or depression underneath it, this is well-trodden clinical ground. If it is depression or PTSD alone, you are in a much less established area — and should be told so.

How ibogaine works →

Screening here is stricter — and this matters

There is a tension on this page that deserves a direct answer rather than being glossed over.

Psychiatric conditions appear on the exclusion list for ibogaine treatment. In the published protocol, absence of psychiatric comorbidity was an inclusion criterion, and psychosis and schizophrenia are explicit contraindications. So how can ibogaine be considered for depression or PTSD at all?

The distinction is between conditions involving psychosis or major mood instability — which are contraindications, without exception — and depression, anxiety or PTSD without psychotic features, which are assessed individually. Bipolar disorder requires particular caution and is frequently excluded.

Medication is the second issue, and on this page it is the bigger one. Most people with depression or PTSD who reach us are taking psychiatric medication — and a number of antidepressants and antipsychotics prolong the QT interval, exactly as ibogaine does. Combining them without review compounds cardiac risk.

This cannot be handled by stopping medication before travelling, either: abrupt discontinuation of psychiatric medication is dangerous in its own right. It requires a physician planning the process well in advance, in coordination with whoever prescribes it.

If you take psychiatric medication, this is the first thing to raise — not a detail to mention on arrival.

Ibogaine side effects and contraindications →

What treatment involves

The protocol does not differ substantially from addiction treatment: screening with an ECG, blood tests and psychological assessment; a period of preparation including psychotherapy; treatment in a hospital or licensed medical facility with dosing by body weight; acute effects lasting around ten hours; and continuous monitoring for 24 to 48 hours.

The difference lies in emphasis rather than procedure. Without a dependence to interrupt, the value of the session rests almost entirely on the introspective phase and on the psychological work that follows it — which makes the quality of the therapeutic support the deciding factor in whether treatment is worth undertaking at all.

The ibogaine experience →

Realistic expectations

Some people describe substantial and lasting change. Others describe a powerful experience whose effects faded without producing durable improvement. Published data does not currently allow anyone to predict which outcome you would have — and any provider claiming otherwise is guessing confidently.

What we would set out plainly:

Ibogaine is not an antidepressant. It is not taken continuously, and it does not work the way SSRIs work.

It does not remove what happened to you. In trauma, the material becomes accessible — processing it is therapeutic work, and that work is not comfortable.

The evidence here is weaker than for addiction. If someone offers you a success rate for ibogaine in depression, ask which published study it comes from.

It is not a first-line treatment. For treatment-resistant depression and PTSD, established options — including newer approved treatments — should generally be explored first with a psychiatrist.

One of our clients described the outcome in terms we would not improve on: the biggest change was not immediate happiness, but finally feeling mentally clear, emotionally stable, and able to function normally again.

Is it appropriate for you?

In our experience, this treatment makes most sense for people whose depression, anxiety or trauma is entangled with dependence — and least sense as a first attempt at treating a mood disorder that has not been properly worked through with a psychiatrist.

We do not own clinics. On this subject in particular we often advise against treatment — because the evidence does not support it in that case, or because the person’s medication makes it unsafe.

If you want an honest assessment rather than an encouraging one, that is what we offer.

Get an honest assessment of your case

Free and confidential. Tell us about your diagnosis and current medication — our team reviews it and replies within 24 hours.

Sources

  1. Schenberg EE, de Castro Comis MA, Alexandre JFM, Chaves BDR, Tófoli LF, da Silveira DX. Treating drug dependence with the aid of ibogaine: a qualitative study. Journal of Psychedelic Studies. 2017;1(1):10–19 (published online 2016). doi:10.1556/2054.01.2016.002

Frequently asked questions

01. Does ibogaine treat depression?
Published clinical evidence concerns addiction, not depression. Research is early. The clearest rationale is where depression sits underneath a dependence.
02. Does ibogaine help PTSD?
Interest is growing and research is under way, but it remains early-stage. Ibogaine's introspective state makes trauma material accessible — the therapy that follows does the work.
03. Can I take ibogaine while on antidepressants?
Not without medical review. Several antidepressants prolong the QT interval as ibogaine does. Never stop psychiatric medication abruptly on your own either — it requires a physician's plan.
04. Is ibogaine safe for bipolar disorder?
Bipolar disorder requires particular caution and is frequently excluded. Psychosis and schizophrenia are outright contraindications.
05. Is ibogaine an antidepressant?
No. It is not taken continuously and does not work like conventional antidepressant medication.
06. What's the success rate for depression?
There is no reliable published figure. Any clinic quoting one should be asked which study it comes from.
07. Should I try ibogaine before other treatments?
Generally no. For depression and PTSD, established options should be explored with a psychiatrist first.

This page is for information only and is not medical advice. Ibogaine is not an approved treatment for depression, PTSD or any psychiatric condition. Never stop or change psychiatric medication without your prescriber's supervision. If you are in crisis or having thoughts of self-harm, contact your local emergency services or a crisis line.

Get a free, confidential assessment

Our consultation is free for you. Medical decisions are made by the clinic's doctors.